CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 49 enrolled
Drug / intervention
Broccoli Sprout/Broccoli Seed Extract Supplement +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03402230
NCT03402230Early Ph 1Completed
CompareCT.gov

Clinical Study of Avmacol® for Detoxification of Tobacco Carcinogens in Heavy Smokers

National Cancer Institute (NCI)·interventional·Posted Jan 18, 2018·Updated Jun 28, 2023

In Brief

A Early Phase 1 clinical trial evaluating Broccoli Sprout/Broccoli Seed Extract Supplement, Laboratory Biomarker Analysis, and 1 other intervention for Cigarette Smoking-Related Carcinoma and Tobacco-Related Carcinoma. Completed, enrolled 49 participants across 2 sites.

Detailed Summary

This randomized early phase I trial studies how well broccoli sprout/broccoli seed extract supplement works in decreasing toxicity in heavy smokers. Broccoli sprout/broccoli seed extract supplement is a dietary supplement made from broccoli sprout and seed extract powder, and may break down some of the cancer causing substances in tobacco smoke and produce substances that may protect cells from tobacco smoke-induced damage in current smokers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCigarette Smoking-Related Carcinoma, Tobacco-Related Carcinoma
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
201820192020202120222023202420252026
First PostedJan 18, 2018
Enrollment StartFeb 20, 2018
Primary CompletionJan 10, 2020
Study CompletionJul 24, 2022
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 8.5 years ago

Interventions

Broccoli Sprout/Broccoli Seed Extract Supplementdrug

Given PO

Laboratory Biomarker Analysisother

Correlative studies

Questionnaire Administrationother

Ancillary studies